Alzheimer's Disease (AD) is a neurological disease that is the most common cause of dementia. Early onset of the disease occurs in patients under the age of 65, which is approximately 5-10% of all diagnosed cases of Alzheimer's. Approximately 13% of this population are patients with Familial Alzheimer’s disease, in which a genetic disposition leads to the disease. The disease leads to memory loss, and in the later stages, an inability to perform daily activities. AD can occur in younger patients due to a mutation in the presenilin 1 (PSEN 1), presenilin 2 (PSEN 2), and amyloid precursor protein (APP) genes.
Alzheimer Disease, Familial Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Alzheimer Disease, Familial below!
For more information on how to use Laverne, please read the How to Guide.
We have 1356 products for the study of Alzheimer Disease, Familial that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Alzheimer Disease, Familial is also known as Familial Alzheimer Disease, Familial Alzheimer's Disease.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.